Literature DB >> 20499210

Association of nuclear factor κB expression with a poor outcome in nasopharyngeal carcinoma.

Y Zhang1, J Y Lang, L Liu, J Wang, G Feng, Y Jiang, Y L Deng, X J Wang, Y H Yang, T Z Dai, G Xie, J Pu, X B Du.   

Abstract

The aim of this study was to determine the relationship between nuclear factor κB and the prognosis of patients with nasopharyngeal carcinoma. We used immunohistochemical studies to examine nuclear factor κB expression in 42 patients with nasopharyngeal carcinoma. The results showed that tumors positive for nuclear factor κB were associated with an increased relapse potential, poor disease-free survival, and reduced overall survival in nasopharyngeal carcinoma. Our study indicates that nuclear factor κB could be an independent molecular marker for predicting poor prognosis among patients with nasopharyngeal carcinoma. Understanding the biology of nuclear factor κB-mediated pathways may lead to the development of novel therapeutic strategies for nasopharyngeal carcinoma.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20499210     DOI: 10.1007/s12032-010-9571-7

Source DB:  PubMed          Journal:  Med Oncol        ISSN: 1357-0560            Impact factor:   3.064


  42 in total

Review 1.  Control of apoptosis by Rel/NF-kappaB transcription factors.

Authors:  M Barkett; T D Gilmore
Journal:  Oncogene       Date:  1999-11-22       Impact factor: 9.867

Review 2.  Control of oncogenesis and cancer therapy resistance by the transcription factor NF-kappaB.

Authors:  A S Baldwin
Journal:  J Clin Invest       Date:  2001-02       Impact factor: 14.808

3.  Inducibility of kappa immunoglobulin enhancer-binding protein Nf-kappa B by a posttranslational mechanism.

Authors:  R Sen; D Baltimore
Journal:  Cell       Date:  1986-12-26       Impact factor: 41.582

4.  High expression levels of nuclear factor kappaB, IkappaB kinase alpha and Akt kinase in squamous cell carcinoma of the oral cavity.

Authors:  H Nakayama; T Ikebe; M Beppu; K Shirasuna
Journal:  Cancer       Date:  2001-12-15       Impact factor: 6.860

5.  Constitutive NF-kappaB activity influences basal apoptosis and radiosensitivity of head-and-neck carcinoma cell lines.

Authors:  C Didelot; M Barberi-Heyob; A Bianchi; P Becuwe; J F Mirjolet; M Dauça; J L Merlin
Journal:  Int J Radiat Oncol Biol Phys       Date:  2001-12-01       Impact factor: 7.038

6.  Significant prognosticators after primary radiotherapy in 903 nondisseminated nasopharyngeal carcinoma evaluated by computer tomography.

Authors:  P Teo; P Yu; W Y Lee; S F Leung; W H Kwan; K H Yu; P Choi; P J Johnson
Journal:  Int J Radiat Oncol Biol Phys       Date:  1996-09-01       Impact factor: 7.038

Review 7.  Function and activation of NF-kappa B in the immune system.

Authors:  P A Baeuerle; T Henkel
Journal:  Annu Rev Immunol       Date:  1994       Impact factor: 28.527

8.  Enhanced radiosensitivity by inhibition of nuclear factor kappa B activation in human malignant glioma cells.

Authors:  N Yamagishi; J Miyakoshi; H Takebe
Journal:  Int J Radiat Biol       Date:  1997-08       Impact factor: 2.694

9.  Nuclear factor-kB tumor expression predicts response and survival in irinotecan-refractory metastatic colorectal cancer treated with cetuximab-irinotecan therapy.

Authors:  Mario Scartozzi; Italo Bearzi; Chiara Pierantoni; Alessandra Mandolesi; Fotios Loupakis; Alberto Zaniboni; Vincenzo Catalano; Antonello Quadri; Fausto Zorzi; Rossana Berardi; Tommasina Biscotti; Roberto Labianca; Alfredo Falcone; Stefano Cascinu
Journal:  J Clin Oncol       Date:  2007-09-01       Impact factor: 44.544

10.  Specific covalent binding of a NF-kappaB decoy hairpin oligonucleotide targeted to the p50 subunit and induction of apoptosis.

Authors:  Denis Lesage; Valeri Metelev; Oksana Borisova; Nina Dolinnaya; Tatiana Oretskaya; Fanny Baran-Marszak; Eliane Taillandier; Martine Raphael; Remi Fagard
Journal:  FEBS Lett       Date:  2003-07-17       Impact factor: 4.124

View more
  6 in total

Review 1.  Chemoprevention of head and neck squamous cell carcinoma through inhibition of NF-κB signaling.

Authors:  Robert Vander Broek; Grace E Snow; Zhong Chen; Carter Van Waes
Journal:  Oral Oncol       Date:  2013-10-28       Impact factor: 5.337

2.  Exome Sequencing Identifies Potentially Druggable Mutations in Nasopharyngeal Carcinoma.

Authors:  Yock Ping Chow; Lu Ping Tan; San Jiun Chai; Norazlin Abdul Aziz; Siew Woh Choo; Paul Vey Hong Lim; Rajadurai Pathmanathan; Noor Kaslina Mohd Kornain; Chee Lun Lum; Kin Choo Pua; Yoke Yeow Yap; Tee Yong Tan; Soo Hwang Teo; Alan Soo-Beng Khoo; Vyomesh Patel
Journal:  Sci Rep       Date:  2017-03-03       Impact factor: 4.379

3.  Roles of β-catenin, TCF-4, and survivin in nasopharyngeal carcinoma: correlation with clinicopathological features and prognostic significance.

Authors:  Pei-Ying Jin; Zi-Hui Zheng; Hong-Jie Lu; Jing Yan; Gui-Hong Zheng; Yuan-Lin Zheng; Dong-Mei Wu; Jun Lu
Journal:  Cancer Cell Int       Date:  2019-02-28       Impact factor: 5.722

4.  Genomic Landscape of Head and Neck Squamous Cell Carcinoma Across Different Anatomic Sites in Chinese Population.

Authors:  Yunhe Ju; Xingrao Wu; Huizhen Wang; Bin Li; Qing Long; Dadong Zhang; Hao Chen; Nianqing Xiao; Fugen Li; Shiwen Zhang; Shenggang Yang
Journal:  Front Genet       Date:  2021-06-14       Impact factor: 4.599

5.  Ent-11α-hydroxy-15-oxo-kaur-16-en-19-oic-acid induces apoptosis and cell cycle arrest in CNE-2Z nasopharyngeal carcinoma cells.

Authors:  Kefeng Wu; Yi Liu; Yingnian Lv; Liao Cui; Wende Li; Jianfa Chen; Nian Ci Liang; Li Li
Journal:  Oncol Rep       Date:  2013-04-03       Impact factor: 3.906

Review 6.  NF-κB Expression and Outcomes in Solid Tumors: A Systematic Review and Meta-Analysis.

Authors:  Dang Wu; Pin Wu; Lufeng Zhao; Lijian Huang; Zhigang Zhang; Shuai Zhao; Jian Huang
Journal:  Medicine (Baltimore)       Date:  2015-10       Impact factor: 1.817

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.